CVE-2008-0919

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in session/login.php in Open Source Security Information Management (OSSIM) 0.9.9 rc5 and earlier allows remote attackers to inject arbitrary web script or HTML via the dest parameter.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 7.20% Top 10%
Third-Party Advisory securityreason.com Third-Party Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://securityreason.com/securityalert/3689 third party advisory
http://www.securityfocus.com/archive/1/488617/100/0/threaded mailing list
http://www.securityfocus.com/archive/1/488697/100/0/threaded mailing list
http://www.securityfocus.com/bid/27929 patch vdb entry exploit
https://www.exploit-db.com/exploits/5171 exploit
http://osvdb.org/42006 vdb entry
http://www.securityfocus.com/archive/1/488450/100/0/threaded mailing list
http://secunia.com/advisories/29046 third party advisory

Frequently Asked Questions

What is the severity of CVE-2008-0919?
CVE-2008-0919 has been scored as a medium severity vulnerability.
How to fix CVE-2008-0919?
To fix CVE-2008-0919, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-0919 being actively exploited in the wild?
It is possible that CVE-2008-0919 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~7% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.